… Despite early evidence of sustained activity of nivolumab from a phase I single-arm study in
heavily pretreated patients with a 5-year OS of 16% (10), so far long-term efficacy and safety …

… samples taken from 103 patients with small cell lung cancer at the time of … pretreatment
S-bFGF was associated with poor overall survival. The 1- and 2-year survival rates of the patients …

… in pretreated patients. This experience, together with the knowledge of the reinduction …
detail prior chemotherapy exposure characteristics of pretreated patients to be enrolled in future …

… lung cancer [27–33]. However, the significance of the NLR as a … in patients with NSCLC.
In this large retrospective study, we systematically evaluated the significance of pretreatment …

… administered as a single agent in pretreated patients. The effectiveness and mild toxicity
profile of gemcitabine encourages its use in patients with locally advanced or metastatic …

… pretreatment levels of the protein were associated with a shorter time to disease progression
and overall survival duration, whereas low pretreatment … 86 patients with lung carcinoma at …

… In summary, pretreatment NLR is independently associated with PFS and OS in patients
with advanced NSCLC treated with nivolumab. It is unclear whether NLR is predictive or …

BACKGROUND Fibroblast growth factor receptor 1 (FGFR1) amplification is a potential
driving oncogene in squamous cell cancer (SCC) of the lung. The current phase 2 study …

… objective of this study is to explore the association between the pretreatment systemic
immune-inflammation index (SII) and prognosis in non-small cell lung cancer (NSCLC) patients. …

… patients with pretreated NSCLC who had initiated programmed cell death protein 1 (PD-1) or
programmed cell … As CT-assessed pretreatment markers, we used psoas muscle index (PMI…